Signaled drug delivery and transport across the blood–brain barrier

References

• Afadzi M, de Davies CL, Hansen YH, et al. (2012). Effect of ultrasound parameters on the release of liposomal calcein. Ultrasound Med Biol 38:476–86
   PubMed Web of Science ®Google Scholar
• Aryal M, Vykhodtseva N, Zhang YZ, et al. (2013). Multiple treatments with liposomal doxorubicin and ultrasound-induced disruption of blood-tumor and blood-brain barriers improve outcomes in a rat glioma model. J Control Release 169:103–11
   PubMed Web of Science ®Google Scholar
• Baeumer B, Chatterjee L, Hinow P, et al. (2009). Predicting the drug release kinetics of matrix tablets. Discr Contin Dyn Sys B 12:261–77
   Web of Science ®Google Scholar
• Ball K, Bouzom F, Scherrmann JM, et al. (2012). Development of a physiologically based pharmacokinetic model for the rat central nervous system and determination of an in vitro-in vivo scaling methodology for the blood-brain barrier permeability of two transporter substrates, morphine and oxycodone. J Pharm Sci 101:4277–92
   PubMed Web of Science ®Google Scholar
• Barber TW, Brockway JA, Higgins LS. (1970). The density of tissues in and about the head. Acta Neurol Scand 46:85–92
   PubMed Web of Science ®Google Scholar
• Bernheimer H, Birkmayer W, Hornykiewicz O, et al. (1973). Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J Neurol Sci 20:415–55
   PubMed Web of Science ®Google Scholar
• Buchla E, Hinow P, Nájera A, Radunskaya A. (2014). Swallowing a cellular automaton pill: predicting drug release from a matrix tablet. Simulation 90:227–37
   Google Scholar
• Burgess A, Hynynen K. (2014). Drug delivery across the blood-brain barrier using focused ultrasound. Expert Opin Drug Deliv 11:711–21
   PubMed Web of Science ®Google Scholar
• Cecchelli R, Berezowski V, Lundquist S, et al. (2007). Modelling of the blood-brain barrier in drug discovery and development. Nat Rev Drug Discov 6:650–61
   PubMed Web of Science ®Google Scholar
• Chase TN. (1998). The significance of continuous dopaminergic stimulation in the treatment of Parkinson’s disease. Drugs 55:1–9
   PubMed Web of Science ®Google Scholar
• Chen H, Konofagou EE. (2014). The size of blood-brain barrier opening induced by focused ultrasound is dictated by the acoustic pressure. J Cereb Blood Flow Metab 34:1197–204
   PubMed Web of Science ®Google Scholar
• Cumming P, Gjedde A. (1998). Compartmental analysis of dopa decarboxylation in living brain from dynamic positron emission tomograms. Synapse 29:37–61
   PubMed Web of Science ®Google Scholar
• David T, van Kempen T, Huang H, Wilson P. (2011). The geometry and dynamics of binary trees. Math Comput Simulat 81:1464–81
   Web of Science ®Google Scholar
• del Amo EM, Urtti A, Yliperttula M. (2008). Pharmacokinetic role of L-type amino acid transporters LAT1 and LAT2. Eur J Pharm Sci 35:161–74
   PubMed Web of Science ®Google Scholar
• Di Stefano A, Carafa M, Sozio P, et al. (2004). Evaluation of rat striatal l-dopa and DA concentration after intraperitoneal administration of l-dopa produgs in liposomal formulations. J Control Release 99:293–300
   PubMed Web of Science ®Google Scholar
• Enden G, Schroeder A. (2009). A mathematical model of drug release from liposomes by low frequency ultrasound. Ann Biomed Eng 37:2640–5
   PubMed Web of Science ®Google Scholar
• Evjen TJ, Hagtvet E, Nilssen EA, et al. (2011a). Sonosensitive dioleoylphosphatidylethanolamine-containing liposomes with prolonged blood circulation time of doxorubicin. Eur J Pharm Sci 43:318–24
   PubMed Web of Science ®Google Scholar
• Evjen TJ, Nilssen EA, Barnert S, et al. (2011b). Ultrasound-mediated destabilization and drug release from liposomes comprising dioleoylphosphatidylethanolamine. Eur J Pharm Sci 42:380–6
   PubMed Web of Science ®Google Scholar
• Fabbrini G, Mouradian MM, Juncos JL, et al. (1988). Motor fluctuations in Parkinson’s disease: central pathophysiological mechanisms, Part I. Ann Neurol 24:366–71
   PubMed Web of Science ®Google Scholar
• Graham SM, Carlisle R, Choi JJ, et al. (2014). Inertial cavitation to non-invasively trigger and monitor intratumoral release of drug from intravenously delivered liposomes. J Control Release 178:101–7
   PubMed Web of Science ®Google Scholar
• Greene RF, Collins JM, Jenkins JF, et al. (1983). Plasma pharmacokinetics of adriamycin and adriamycinol: implications for the design of in vitro experiments and treatment protocols. Cancer Res 43:3417–21
   PubMed Web of Science ®Google Scholar
• Grüll H, Langereis S. (2012). Hyperthermia-triggered drug delivery from temperature-sensitive liposomes using MRI-guided high intensity focused ultrasound. J Control Release 161:317–27
   PubMed Web of Science ®Google Scholar
• Gugat M. (2012). Contamination source determination in water distribution networks. SIAM J Appl Math 72:1772–91
   Web of Science ®Google Scholar
• Haran G, Cohen R, Bar LK, Barenholz Y. (1993). Transmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of amphipathic weak bases. BBA Biomembranes 1151:201–15
   PubMed Web of Science ®Google Scholar
• Hayashi T, Watabe H, Kudomi N, et al. (2003). A theoretical model of oxygen delivery and metabolism for physiologic interpretation of quantitative cerebral blood flow and metabolic rate of oxygen. J Cereb Blood Flow Metab 23:1314–23
   PubMed Web of Science ®Google Scholar
• Hinow, P, Radunskaya AE. (2014). The mathematics of drug delivery. In: Eladdadi A, Kim PS, Mallet D, eds. Mathematical modeling of tumor-immune system dynamics. Berlin, Heidelberg (New York): Springer Verlag, 109–23
   Google Scholar
• Hinow P, Radunskaya A, Tucker I, Yang L. (2012). Kinetics of bile salt binding to liposomes revealed by carboxyfluorescein release and mathematical modeling. J Liposome Res 22:237–44
   PubMed Web of Science ®Google Scholar
• Huang SC, Yu DC, Barrio JR, et al. (1991). Kinetics and modeling of L-6-[18F]fluoro-dopa in human positron emission tomographic studies. J Cereb Blood Flow Metab 11:898–913
   PubMed Web of Science ®Google Scholar
• Hynynen K, McDannold N, Sheikov NA, et al. (2005). Local and reversible blood–brain barrier disruption by noninvasive focused ultrasound at frequencies suitable for trans-skull sonications. NeuroImage 24:12–20
   PubMed Web of Science ®Google Scholar
• Ishida T, Harashima H, Kiwada H. (2002). Liposome clearance. Biosci Rep 22:197–224
   PubMed Web of Science ®Google Scholar
• Jespersen SN, Østergaard L. (2012). The roles of cerebral blood flow, capillary transit time heterogeneity, and oxygen tension in brain oxygenation and metabolism. J Cereb Blood Flow Metab 32:264–77
   PubMed Web of Science ®Google Scholar
• Johnston TH, Fox SH, Brotchie JM. (2005). Advances in the delivery of treatments for Parkinson’s disease. Expert Opin Drug Deliv 2:1059–73
   PubMedGoogle Scholar
• Kang, K, Wen, S, Yamabe, Y, et al. (2010). Dual beneficial effects of (-)epigallocatechin-3-gallate on levodopa methylation and hippocampal neurodegeneration: in vitro and in vivo studies. PLoS One 5:e11951
   PubMed Web of Science ®Google Scholar
• Karbowski J. (2011). Scaling of brain metabolism and blood flow in relation to capillary and neural scaling. PLoS One 6:e26709
   Google Scholar
• Khor SP, Hsu A. (2007). The pharmacokinetics and pharmacodynamics of levodopa in the treatment of Parkinson’s disease. Curr Clin Pharmacol 2:234–43
   PubMedGoogle Scholar
• Killian DM, Chikhale PJ. (2001). Predominant functional activity of the large, neutral amino acid transporter (LAT1) isoform at the cerebrovasculature. Neurosci Lett 306:1–4
   PubMed Web of Science ®Google Scholar
• Kim M, Gillies R, Rejniak KA. (2013). Current advances in mathematical modeling of anti-cancer drug penetration into tumor tissues. Front Oncol 3:278
   PubMedGoogle Scholar
• Kleinfeld D, Mitra PP, Helmchen F, Denk W. (1998). Fluctuations and stimulus-induced changes in blood flow observed in individual capillaries in layers 2 through 4 of rat neocortex. Proc Natl Acad Sci USA 95:15741–6
   PubMed Web of Science ®Google Scholar
• Ledzewicz U, Schättler H. (2012). Geometric optimal control – theory, methods and examples. Vol 38. Berlin, Heidelberg, New York: Springer Verlag
   Google Scholar
• Liu HL, Hua MY, Yang HW, et al. (2010). Magnetic resonance monitoring of focused ultrasound/magnetic nanoparticle targeting delivery of therapeutic agents to the brain. Proc Natl Acad Sci USA 107:15205–10
   PubMed Web of Science ®Google Scholar
• Liu K, Smith BJ, Chen C, et al. (2005). Use of a physiologically based pharmacokinetic model to study the time to reach brain equilibrium: an experimental analysis of the role of blood-brain barrier permeability, plasma protein binding, and brain tissue binding. J Pharmacol Exp Ther 313:1254–62
   PubMed Web of Science ®Google Scholar
• Lotharius J, Brundin P. (2002). Pathogenesis of Parkinson’s disease: dopamine, vesicles and alpha-synuclein. Nat Rev Neurosci 3:932–42
   PubMed Web of Science ®Google Scholar
• Mura S, Nicolas J, Couvreur P. (2013). Stimuli-responsive nanocarriers for drug delivery. Nat Mater 12:1–9
   PubMed Web of Science ®Google Scholar
• Olanow W, Schapira AH, Rascol O. (2000). Continuous dopamine-receptor stimulation in early Parkinson’s disease. Trends Neurosci 23:S117–26
   PubMed Web of Science ®Google Scholar
• Pardridge WM, Tiguero D, Yang J, Pasquale AC. (1990). Comparison of in vitro and in vivo models of drug transcytosis through the blood-brain barrier. J Pharmacol Exp Ther 253:884–91
   PubMed Web of Science ®Google Scholar
• Paul BK, Ray D, Guchlait N. (2013). Unraveling the binding interaction and kinetics of a prospective anti-HIV drug with a model transport protein: results and challenges. Phys Chem Chem Phys 15:1275–87
   PubMed Web of Science ®Google Scholar
• Peppas NA, Narasimhan B. (2014). Mathematical models in drug delivery: how modeling has shaped the way we design new drug delivery systems. J Control Release 190:75–81
   PubMed Web of Science ®Google Scholar
• R Core Team. (2014) R: a language and environment for statistical computing. Vienna, Austria. Available from: www.R-project.org
   Google Scholar
• Rejniak KA, Estrella V, Chen T, et al. (2013). The role of tumor tissue architecture in treatment penetration and efficacy: an integrative study. Front Oncol 3:111
   PubMedGoogle Scholar
• Richardson G, Kaouri K, Byrne HM. (2010). Particle trapping by an external body force in the limit of large Peclet number: applications to magnetic targeting in the blood flow. Eur J Appl Math 21:77–107
   Web of Science ®Google Scholar
• Safaeian N, Sellier M, David T. (2011). A computational model of hemodynamic parameters in cortical capillary networks. J Theor Biol 271:145–56
   PubMed Web of Science ®Google Scholar
• Scilab Enterprises. (2012). Scilab: Free and Open Source software for numerical computation. Orsay, France. Available from: www.scilab.org
   Google Scholar
• Sevilla P, Rivas JM, García-Blanco F, et al. (2007). Identification of the antitumoral drug emodin binding sites in bovine serum albumin by spectroscopic methods. Biochim Biophys Acta 1774:1359–69
   PubMed Web of Science ®Google Scholar
• Smith RV, Velagapudi RB, McLean AM, Wilcox RE. (1985). Interactions of apomorphine with serum and tissue proteins. J Med Chem 28:613–20
   PubMed Web of Science ®Google Scholar
• Staruch R, Chopra R, Hynynen K. (2011). Localised drug release using MRI-controlled focused ultrasound hyperthermia. Int J Hyperthermia 27:391–8
   Web of Science ®Google Scholar
• Stewart JC. (1980). Colorimetric determination of phospholipids with ammonium ferrothiocyanate. Anal Biochem 104:10–14
   PubMed Web of Science ®Google Scholar
• ter Haar G. (2010). Ultrasound bioeffects and safety. Proc Inst Mech Eng H 224:363–73
   PubMed Web of Science ®Google Scholar
• Th. Bär. (1980). The vascular system of the cerebral cortex. Vol 59. Berlin, Heidelberg (New York): Springer Verlag
   Google Scholar
• Thanvi B, Lo N, Robinson T. (2007). Levodopa-induced dyskinesia in Parkinson’s disease: clinical features, pathogenesis, prevention and treatment. Postgrad Med J 83:384–8
   PubMed Web of Science ®Google Scholar
• Treat LH, McDannold N, Vykhodtseva N, et al. (2007). Targeted delivery of doxorubicin to the rat brain at therapeutic levels using MRI-guided focused ultrasound. Int J Cancer 121:901–7
   PubMed Web of Science ®Google Scholar
• Tucker I, Yang L, Mujoo H. (2012). Delivery of drugs to the brain via the blood brain barrier using colloidal carriers. J Microencapsul 29:475–86
   PubMed Web of Science ®Google Scholar
• Uchino H, Kanai Y, Kim DK, et al. (2002). Transport of amino acid-related compounds mediated by l-type amino acid transporter 1 (LAT1): insights into the mechanisms of substrate recognition. Mol Pharmacol 61:729–37
   PubMed Web of Science ®Google Scholar
• van der Graaf PH, Benson N. (2011). Systems pharmacology: bridging systems biology and pharmacokinetics-pharmacodynamics (pkpd) in drug discovery and development. Pharm Res 28:1460–4
   PubMed Web of Science ®Google Scholar
• Wrenn SP, Dicker SM, Small EF, et al. (2012). Bursting bubbles and bilayers. Theranostics 2:12
   Web of Science ®Google Scholar
• Xiang Y, Wu Q, Liang L, et al. (2012). Chlorotoxin-modified stealth liposomes encapsulating levodopa for the targeting delivery against the parkinson’s disease in the MPTP-induced mice model. J Drug Target 20:67–75
   PubMed Web of Science ®Google Scholar